Aghion Daniel 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 8, 2024
Insider Transaction Report
Form 4
Aghion Daniel
Director
Transactions
- Award
Common Stock
2024-01-04+5,070→ 35,070 total - Award
Common Stock
2024-01-04+30,000→ 30,000 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.